Lytic infection of Kaposi’s sarcoma-associated herpesvirus induces DNA double-strand breaks and impairs non-homologous end joining

References

1. Ablashi D. V., Chatlynne L. G., Whitman J. E. Jr, Cesarman E. 2002; Spectrum of Kaposi’s sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin Microbiol Rev 15:439–464 [View Article][PubMed]
   [Google Scholar]
2. An J., Sun Y., Fisher M., Rettig M. B. 2004; Antitumor effects of bortezomib (PS-341) on primary effusion lymphomas. Leukemia 18:1699–1704 [View Article][PubMed]
   [Google Scholar]
3. Burma S., Chen B. P., Chen D. J. 2006; Role of non-homologous end joining (NHEJ) in maintaining genomic integrity. DNA Repair (Amst) 5:1042–1048 [View Article][PubMed]
   [Google Scholar]
4. Casper C. 2005; The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br J Haematol 129:3–17 [View Article][PubMed]
   [Google Scholar]
5. Chen X., Lin K., Ricciardi R. P. 2004; Human Kaposi’s sarcoma herpesvirus processivity factor-8 functions as a dimer in DNA synthesis. J Biol Chem 279:28375–28386 [View Article][PubMed]
   [Google Scholar]
6. Chronowski G. M., Ha C. S., Wilder R. B., Cabanillas F., Manning J., Cox J. D. 2001; Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer 92:670–676 [View Article][PubMed]
   [Google Scholar]
7. Deriano L., Guipaud O., Merle-Béral H., Binet J. L., Ricoul M., Potocki-Veronese G., Favaudon V., Maciorowski Z., Muller C.& other authors ( 2005; Human chronic lymphocytic leukemia B cells can escape DNA damage-induced apoptosis through the nonhomologous end-joining DNA repair pathway. Blood 105:4776–4783 [View Article][PubMed]
   [Google Scholar]
8. Fowler R. A., Meyskens F. L. Jr 1978; Tumor viruses and human cancer. II. DNA tumor viruses. Ariz Med 35:661–662, 666–667[PubMed]
   [Google Scholar]
9. Gaspar M., Shenk T. 2006; Human cytomegalovirus inhibits a DNA damage response by mislocalizing checkpoint proteins. Proc Natl Acad Sci U S A 103:2821–2826 [View Article][PubMed]
   [Google Scholar]
10. Gholam D., Vantelon J. M., Al-Jijakli A., Bourhis J. H. 2003; A case of multicentric Castleman’s disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody. Ann Hematol 82:766–768 [View Article][PubMed]
    [Google Scholar]
11. Green M., Wold W. S. 1976; Oncogenic DNA viruses–replication, tumor gene expression, and role in human cancer. Semin Oncol 3:65–79[PubMed]
    [Google Scholar]
12. Hayward G. S. 2003; Initiation of angiogenic Kaposi’s sarcoma lesions. Cancer Cell 3:1–3 [View Article][PubMed]
    [Google Scholar]
13. Herrada J., Cabanillas F., Rice L., Manning J., Pugh W. 1998; The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med 128:657–662 [View Article][PubMed]
    [Google Scholar]
14. Jenner R. G., Albà M. M., Boshoff C., Kellam P. 2001; Kaposi’s sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J Virol 75:891–902 [View Article][PubMed]
    [Google Scholar]
15. Jha H. C., Upadhyay S. K., Aj M. P., Lu J., Cai Q., Saha A., Robertson E. S. 2013; H2AX phosphorylation is important for LANA-mediated Kaposi’s sarcoma-associated herpesvirus episome persistence. J Virol 87:5255–5269 [View Article][PubMed]
    [Google Scholar]
16. Kao J., Rosenstein B. S., Peters S., Milano M. T., Kron S. J. 2005; Cellular response to DNA damage. Ann N Y Acad Sci 1066:243–258 [View Article][PubMed]
    [Google Scholar]
17. Kudoh A., Fujita M., Zhang L., Shirata N., Daikoku T., Sugaya Y., Isomura H., Nishiyama Y., Tsurumi T. 2005; Epstein–Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an S-phase-like cellular environment. J Biol Chem 280:8156–8163 [View Article][PubMed]
    [Google Scholar]
18. Kumari P., Schechter G. P., Saini N., Benator D. A. 2000; Successful treatment of human immunodeficiency virus-related Castleman’s disease with interferon-alpha. Clin Infect Dis 31:602–604 [View Article][PubMed]
    [Google Scholar]
19. Lord C. J., Ashworth A. 2012; The DNA damage response and cancer therapy. Nature 481:287–294 [View Article][PubMed]
    [Google Scholar]
20. Mladenov E., Kalev P., Anachkova B. 2009; The complexity of double-strand break ends is a factor in the repair pathway choice. Radiat Res 171:397–404 [View Article][PubMed]
    [Google Scholar]
21. Nair P., Pan H., Stallings R. L., Gao S. J. 2006; Recurrent genomic imbalances in primary effusion lymphomas. Cancer Genet Cytogenet 171:119–121 [View Article][PubMed]
    [Google Scholar]
22. Nishimoto N., Kanakura Y., Aozasa K., Johkoh T., Nakamura M., Nakano S., Nakano N., Ikeda Y., Sasaki T.& other authors ( 2005; Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood 106:2627–2632 [View Article][PubMed]
    [Google Scholar]
23. Pan H., Zhou F., Gao S. J. 2004; Kaposi’s sarcoma-associated herpesvirus induction of chromosome instability in primary human endothelial cells. Cancer Res 64:4064–4068 [View Article][PubMed]
    [Google Scholar]
24. Pastwa E., Błasiak J. 2003; Non-homologous DNA end joining. Acta Biochim Pol 50:891–908[PubMed]
    [Google Scholar]
25. Pastwa E., Neumann R. D., Mezhevaya K., Winters T. A. 2003; Repair of radiation-induced DNA double-strand breaks is dependent upon radiation quality and the structural complexity of double-strand breaks. Radiat Res 159:251–261 [View Article][PubMed]
    [Google Scholar]
26. Popescu N. C., Zimonjic D. B., Leventon-Kriss S., Bryant J. L., Lunardi-Iskandar Y., Gallo R. C. 1996; Deletion and translocation involving chromosome 3 (p14) in two tumorigenic Kaposi’s sarcoma cell lines. J Natl Cancer Inst 88:450–455 [View Article][PubMed]
    [Google Scholar]
27. Pyakurel P., Montag U., Castaños-Vélez E., Kaaya E., Christensson B., Tönnies H., Biberfeld P., Heiden T. 2006; CGH of microdissected Kaposi’s sarcoma lesions reveals recurrent loss of chromosome Y in early and additional chromosomal changes in late tumour stages. AIDS 20:1805–1812 [View Article][PubMed]
    [Google Scholar]
28. Rogakou E. P., Pilch D. R., Orr A. H., Ivanova V. S., Bonner W. M. 1998; DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 273:5858–5868 [View Article][PubMed]
    [Google Scholar]
29. Seluanov A., Mittelman D., Pereira-Smith O. M., Wilson J. H., Gorbunova V. 2004; DNA end joining becomes less efficient and more error-prone during cellular senescence. Proc Natl Acad Sci U S A 101:7624–7629 [View Article][PubMed]
    [Google Scholar]
30. Shirata N., Kudoh A., Daikoku T., Tatsumi Y., Fujita M., Kiyono T., Sugaya Y., Isomura H., Ishizaki K., Tsurumi T. 2005; Activation of ataxia telangiectasia-mutated DNA damage checkpoint signal transduction elicited by herpes simplex virus infection. J Biol Chem 280:30336–30341 [View Article][PubMed]
    [Google Scholar]
31. Thompson S. L., Compton D. A. 2011; Chromosomes and cancer cells. Chromosome Res 19:433–444 [View Article][PubMed]
    [Google Scholar]
32. Valladares Y. 1967; Cancerigenic viruses neoformed in in vitro cultured cells starting on DNA from human cancer cells. Med Pharmacol Exp Int J Exp Med 16:311–324[PubMed]
    [Google Scholar]